Verve Therapeutics
VERV
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.67 | -0.58 | 0.09 | 13.43% |
| Revenue | 4.94M | 13.1M | 8.14M | 164.78% |
WhatIF - Earnings
EPS Beat Expectations by $0.09
Verve Therapeutics (VERV:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything